-+ 0.00%
-+ 0.00%
-+ 0.00%

Cocrystal Pharma Q3 EPS $(0.19) Beats $(0.21) Estimate

Benzinga·11/14/2025 13:27:12
Listen to the news
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 61.22 percent increase over losses of $(0.49) per share from the same period last year.